InvestorsHub Logo

JohnCM

12/30/19 1:29 AM

#63441 RE: mc73 #63440

Overweight CVSI at 0.89

ap17

12/30/19 12:40 PM

#63453 RE: mc73 #63440

They're hanging on to it for a reason. agreed

Deetew

12/30/19 1:06 PM

#63456 RE: mc73 #63440

Most FDA officials are probably heavily invested in big pharma aside from the revolving door thing they have going on with them. Congress ought to reel them in. Too much conflict of interest, which I'm sure the country's founders would scoff at. So much for "draining the swamp."

https://fortune.com/2017/03/29/fda-gottlieb-pharma-payments/

MartyTamreau

12/30/19 1:51 PM

#63460 RE: mc73 #63440

mc73: Lots will happen before then. Please know that CVSI is filing a CTA (in Europe), not an IND (investigational new drug) which is in the US. We should have phase 1/2 results before the end of 2020 or Q1 2021 (this study should not take long to enroll or conduct.

We need FDA guidance on the supplement and we'll definitely have it by Q2 2020.

You are right, the drug asset is worth a lot.

Happy New Year.

MT